Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)

Completed · Phase 1/Phase 2

Conditions studied: Chorioamnionitis, Brain Injury

In brief

The purpose of this trial was to find the best dose of N-acetylcysteine (NAC) to decrease brain injury in babies exposed to intrauterine infection without causing significant side effects.

Key facts

Study ID
NCT00724594
Run by
Medical University of South Carolina
People needed
46
Starts
2008-08-01
Expected to finish
2014-08-01
Last updated by the study team
2021-04-12

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.